Soumya (Som) Banerjee
CEO and Co-founder
Juvion Life Sciences
Lausanne, Switzerland
Using a novel platform and innovative research, we develop therapies to sustain mobility and delay sarcopenia with age.
My organisation
About me
My organisation
Mobility decline is a major challenge in aging, often linked to motor system deterioration, especially in neuron-muscle communication. Juvion Life Sciences (JLS) has uncovered innovative biological mechanisms to preserve motor circuitry structure and function, promoting better mobility and delaying conditions like sarcopenia. Utilizing AI, a novel in vivo platform, and non-invasive muscle physiology assessments, Juvion is committed to discovering and developing new, safe, and effective therapeutics, to stabilize the motor system and combat mobility loss, making them accessible to all aging individuals.
Speaker sessions (1)
Tuesday, 10 December 2024
10:15 - 11:20
Pitch Sessions Healthtech
Experience the forefront of healthtech innovation at EPFL Investor Day!